MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2025.127495

Медицинская библиотека · Vaccine · 2025

Lyme disease vaccine acceptability among healthcare providers - United States, 2018 and 2022.

Bostic Taylor D, Hook Sarah A, Marx Grace E

СтатьяПеревод в очереди

Аннотация

BACKGROUND

A Lyme disease (LD) vaccine is expected to become available soon. We aimed to understand recent trends in healthcare provider (HCP) willingness to recommend LD vaccination.

METHODS

Cross-sectional surveys among HCPs were conducted in 2018 and 2022. We compared willingness to recommend LD vaccination by survey year and provider characteristics.

RESULTS

Among 3005 HCPs, 70.5 % reported willingness to recommend LD vaccination. This proportion was lower in 2022 than in 2018 (68 % vs 73 %; p < 0.01) and did not differ significantly by provider medical specialty. More HCPs in states with high LD incidence were willing to recommend the vaccine compared to HCPs in neighboring or low-incidence states (p < 0.01). Vaccine safety was the most frequently reported consideration for recommending LD vaccination (73 %).

CONCLUSIONS

HCP willingness to recommend LD vaccination decreased from 2018 to 2022. Vaccination education tailored to HCPs that address vaccine safety will be critical for a successful LD vaccination program.

Для цитирования: Bostic Taylor D, Hook Sarah A, Marx Grace E. Lyme disease vaccine acceptability among healthcare providers - United States, 2018 and 2022.. Vaccine. 2025. DOI: 10.1016/j.vaccine.2025.127495.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.